The direct answer is that the supplied brief presents a potential disclosure-consistency issue, not a settled finding. Plant Doctor says its authorized specialty stores are distributor-operated and that it does not charge franchise fees, management fees, or brand-use fees. The brief also reports that the company's website used franchise-support language and described support covering site selection, store image design, opening preparation, training, opening activities, and later operations. The key unresolved question is whether those two descriptions accurately describe the same business model or create an information-disclosure mismatch during the IPO process.
| Primary source | Wallstreetcn |
|---|---|
| Reported at | 2026-07-14T11:06:00.000Z |
| Topic | 公司 |
| Evidence limit | Reported facts are separated from interpretation; current prices and platform terms require independent verification. |
Evaluate BINANCE for your use case
Check regional eligibility, current fees and product availability on the official destination.
Review BINANCEWhat Happened
Plant Doctor, a cosmetics company with a large offline store base, has updated its IPO prospectus and is continuing its push for the Shanghai main board, according to the supplied brief.
The controversy is about how the company describes its offline store network. In IPO-facing materials, Plant Doctor emphasizes a distribution model. In merchant-facing language reported in the brief, the company used a franchise-support page and described a full set of support services for store operators.
Why The Label Matters
The distinction matters because Plant Doctor's offline network is central to the business described in the brief. At the end of 2025, the company had 4,268 offline chain stores, including 480 directly operated terminal stores and 3,788 authorized specialty stores opened by distributors.
The brief says distribution generated 1.402 billion yuan of revenue in 2025, accounting for more than 60% of total revenue. When a channel contributes that much revenue, investors need clear information about control, economics, risk allocation, and how store operators are recruited and supported.
Company Position And Reported Website Language
In response to the first inquiry, Plant Doctor denied that its sales model belonged to a franchise model. The core explanation reported in the brief was that the company does not charge franchise fees, management fees, or brand-use fees, and that its profit mainly comes from selling products to distributors.
The reported website language creates the tension. The brief says the company's site had a franchise-support page under a join-us section and offered store-location assessment, store-image design, cashier software support, pre-opening training, monthly special training, opening preparation, opening-event support, and later operational coaching.
Financial Context
The disclosure question sits alongside slowing financial performance. In 2025, Plant Doctor's revenue was 2.167 billion yuan, up only 0.53% year over year, while attributable net profit was 218 million yuan, down more than 10%, according to the supplied brief.
The brief also compares Plant Doctor with listed cosmetics peers and says the average 2025 revenue of Proya, Botanee, Marubi, and Syoung was 6.098 billion yuan, about 2.8 times Plant Doctor's revenue. That comparison frames the main-board positioning question without proving the IPO outcome.
Store Discipline And Online Shift
Plant Doctor is described as pursuing both offline contraction and online growth. The brief says the number of authorized distributor stores at the end of 2025 was 3,788, down by 336 from 2023, as the company strengthened single-store cost-benefit assessment and closed some low-efficiency stores through discussions with distributors.
The company is also trying to extend offline relationships into online sales. The brief says Xiaozhi Mall generated 183 million yuan in 2025, close to 10% of revenue, and lets consumers enter through store or sales-associate QR codes, bind to a store, and choose store pickup or direct company delivery.
Evidence Limits
This article uses only the supplied event brief as factual source material. It does not independently verify the latest prospectus, the inquiry response, the company's website, regulator files, store contracts, or current IPO status.
Because of that evidence limit, the article should be read as a decision guide based on the supplied brief, not as a final legal, accounting, regulatory, or investment conclusion. The question remains whether Plant Doctor can explain the wording and business substance clearly enough for readers and reviewers.
Practical Checks
Before relying on this story, check the latest prospectus and inquiry replies for how Plant Doctor defines distribution, store control, brand use, fees, profit source, risk bearing, and distributor obligations. Those details are more important than the label alone.
Also compare merchant-facing recruitment language with IPO-facing disclosure language. If the same store system is described differently for different audiences, the useful next question is whether the differences are cosmetic wording, business shorthand, or a substantive disclosure issue.
For market readers using this type of company event as part of a broader watchlist, keep the analysis separate from trade execution. If you decide to use the supplied Binance path, the provided URL is BINANCE official destination and the code is 7nfg8123. Check the terms shown to you and your own risk tolerance before using any platform.
Evaluate BINANCE for your use case
Check regional eligibility, current fees and product availability on the official destination.
Review BINANCEAffiliate link · Availability varies by region · No guaranteed outcomeQuestions readers ask
Is Plant Doctor's offline network definitely a franchise model?
The supplied brief does not establish that as a final conclusion. It says the company denies having a franchise model and argues that it does not charge franchise fees, management fees, or brand-use fees. The issue is that the website language reportedly used franchise-support wording for merchants.
Why is the distribution-versus-franchise question important?
It is important because the offline distributor network is a major revenue source. The brief says distribution revenue was 1.402 billion yuan in 2025, more than 60% of total revenue, so readers need clarity on control, fees, profit source, and risk allocation.
What do the 2025 financial numbers suggest?
The supplied brief suggests growth pressure. Revenue was 2.167 billion yuan in 2025, up 0.53%, while attributable net profit was 218 million yuan, down more than 10%. Those figures point to a slower growth profile during the IPO push.
Does the reported website language prove inconsistent disclosure?
Not by itself. It raises a question that needs further explanation. The practical issue is whether IPO documents and merchant-facing materials describe the same business substance consistently, especially around store support, brand use, operating control, fees, and risk.
How should readers use this guide if they also follow crypto markets?
Use it as a checklist for reading company-event risk, not as a trading signal. If the supplied Binance referral path is relevant to your own platform choice, review the displayed terms and risks first. This article does not provide financial advice or promise any trading, registration, ranking, or reward outcome.